» Articles » PMID: 38183042

Blood-brain Borders: a Proposal to Address Limitations of Historical Blood-brain Barrier Terminology

Overview
Publisher Biomed Central
Date 2024 Jan 5
PMID 38183042
Authors
Affiliations
Soon will be listed here.
Abstract

Many neuroscientists use the term Blood-Brain Barrier (BBB) to emphasize restrictiveness, often equating or reducing the notion of BBB properties to tight junction molecules physically sealing cerebral endothelial cells, rather than pointing out the complexity of this biological interface with respect to its selectivity and variety of exchange between the general blood circulation and the central nervous tissue. Several authors in the field find it unfortunate that the exquisitely dynamic interfaces between blood and brain continue to be viewed primarily as obstructive barriers to transport. Although the term blood-brain interface is an excellent descriptor that does not convey the idea of a barrier, it is important and preferable for the spreading of an idea beyond specialist communities to try to appeal to well-chosen metaphors. Recent evidence reviewed here indicates that blood-brain interfaces are more than selective semi-permeable membranes in that they display many dynamic processes and complex mechanisms for communication. They are thus more like 'geopolitical borders'. Furthermore, some authors working on blood-brain interface-relevant issues have started to use the word border, for example in border-associated macrophages. Therefore, we suggest adopting the term Blood-Brain Border to better communicate the flexibility of and movement across blood-brain interfaces.

Citing Articles

Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.

Rahman M, Jalouli M, Yadab M, Al-Zharani M Cancers (Basel). 2025; 17(4).

PMID: 40002294 PMC: 11852615. DOI: 10.3390/cancers17040701.


The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications.

Banks W, Rhea E, Reed M, Erickson M Cell Rep Med. 2024; 5(11):101760.

PMID: 39383873 PMC: 11604479. DOI: 10.1016/j.xcrm.2024.101760.


Microbiota-gut-brain axis: interplay between microbiota, barrier function and lymphatic system.

Zhuang M, Zhang X, Cai J Gut Microbes. 2024; 16(1):2387800.

PMID: 39182226 PMC: 11346530. DOI: 10.1080/19490976.2024.2387800.


Transient Receptor Potential Channels in the Healthy and Diseased Blood-Brain Barrier.

Rezzani R, Favero G, Giano M, Pinto D, Labanca M, van Noorden C J Histochem Cytochem. 2024; 72(4):199-231.

PMID: 38590114 PMC: 11020746. DOI: 10.1369/00221554241246032.

References
1.
Strazielle N, Ghersi-Egea J . Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol. 2000; 59(7):561-74. DOI: 10.1093/jnen/59.7.561. View

2.
Fabriek B, van Haastert E, Galea I, Polfliet M, Dopp E, van den Heuvel M . CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia. 2005; 51(4):297-305. DOI: 10.1002/glia.20208. View

3.
Hartz A, Zhong Y, Wolf A, LeVine 3rd H, Miller D, Bauer B . Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. J Neurosci. 2016; 36(6):1930-41. PMC: 4748076. DOI: 10.1523/JNEUROSCI.0350-15.2016. View

4.
Cordon-Cardo C, OBrien J, CASALS D, Biedler J, Melamed M, Bertino J . Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989; 86(2):695-8. PMC: 286540. DOI: 10.1073/pnas.86.2.695. View

5.
Vanlandewijck M, He L, Mae M, Andrae J, Ando K, Del Gaudio F . A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018; 554(7693):475-480. DOI: 10.1038/nature25739. View